 Elizabeth G. Nabel, M.D.
| Title | Professor of Medicine |
|---|
| Institution | Brigham and Women's Hospital |
|---|
| Department | Medicine |
|---|
| Address | Bwh
c/o Executive Offices-PB-4-408
15 Francis St
Boston MA 02115
|
|---|
| Phone | 617/732-5537 |
|---|
|
|
|
 Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
Faculty can login to make corrections and additions.
-
Manceau V, Kremmer E, Nabel EG, Maucuer A. The protein kinase KIS impacts gene expression during development and fear conditioning in adult mice. PLoS One. 2012; 7(8):e43946.
-
Nabel EG, Braunwald E. A tale of coronary artery disease and myocardial infarction. N Engl J Med. 2012 Jan 5; 366(1):54-63.
-
Nabel EG. Cardiovascular insights from a premature aging syndrome: a translational story. Trans Am Clin Climatol Assoc. 2012; 123:221-6.
-
O'Donnell CJ, Nabel EG. Genomics of cardiovascular disease. N Engl J Med. 2011 Dec 1; 365(22):2098-109.
-
Dalloneau E, Pereira PL, Brault V, Nabel EG, Hérault Y. Prmt2 regulates the lipopolysaccharide-induced responses in lungs and macrophages. J Immunol. 2011 Nov 1; 187(9):4826-34.
-
Bökenkamp R, Raz V, Venema A, Deruiter MC, van Munsteren C, Olive M, Nabel EG, Gittenberger-de Groot AC. Correction: Differential Temporal and Spatial Progerin Expression during Closure of the Ductus Arteriosus in Neonates. PLoS One. 2011; 6(9).
-
Bökenkamp R, Raz V, Venema A, DeRuiter MC, van Munsteren C, Olive M, Nabel EG, Gittenberger-de Groot AC. Differential temporal and spatial progerin expression during closure of the ductus arteriosus in neonates. PLoS One. 2011; 6(9):e23975.
-
Sampietro ML, Trompet S, Verschuren JJ, Talens RP, Deelen J, Heijmans BT, de Winter RJ, Tio RA, Doevendans PA, Ganesh SK, Nabel EG, Westra HJ, Franke L, van den Akker EB, Westendorp RG, Zwinderman AH, Kastrati A, Koch W, Slagboom PE, de Knijff P, Jukema JW. A genome-wide association study identifies a region at chromosome 12 as a potential susceptibility locus for restenosis after percutaneous coronary intervention. Hum Mol Genet. 2011 Dec 1; 20(23):4748-57.
-
Cao K, Blair CD, Faddah DA, Kieckhaefer JE, Olive M, Erdos MR, Nabel EG, Collins FS. Progerin and telomere dysfunction collaborate to trigger cellular senescence in normal human fibroblasts. J Clin Invest. 2011 Jul; 121(7):2833-44.
-
Kovacic JC, Moreno P, Nabel EG, Hachinski V, Fuster V. Cellular senescence, vascular disease, and aging: part 2 of a 2-part review: clinical vascular disease in the elderly. Circulation. 2011 May 3; 123(17):1900-10.
-
Kovacic JC, Moreno P, Hachinski V, Nabel EG, Fuster V. Cellular senescence, vascular disease, and aging: part 1 of a 2-part review. Circulation. 2011 Apr 19; 123(15):1650-60.
-
Verstraeten VL, Peckham LA, Olive M, Capell BC, Collins FS, Nabel EG, Young SG, Fong LG, Lammerding J. Protein farnesylation inhibitors cause donut-shaped cell nuclei attributable to a centrosome separation defect. Proc Natl Acad Sci U S A. 2011 Mar 22; 108(12):4997-5002.
-
Ganesh SK, Joo J, Skelding K, Mehta L, Zheng G, O'Neill K, Billings EM, Helgadottir A, Andersen K, Thorgeirsson G, Gudnason T, Geller NL, Simari RD, Holmes DR, O'Neill WW, Nabel EG. Time course analysis of gene expression identifies multiple genes with differential expression in patients with in-stent restenosis. BMC Med Genomics. 2011; 4:20.
-
Olive M, Harten I, Mitchell R, Beers JK, Djabali K, Cao K, Erdos MR, Blair C, Funke B, Smoot L, Gerhard-Herman M, Machan JT, Kutys R, Virmani R, Collins FS, Wight TN, Nabel EG, Gordon LB. Cardiovascular pathology in Hutchinson-Gilford progeria: correlation with the vascular pathology of aging. Arterioscler Thromb Vasc Biol. 2010 Nov; 30(11):2301-9.
-
Iwasaki H, Kovacic JC, Olive M, Beers JK, Yoshimoto T, Crook MF, Tonelli LH, Nabel EG. Disruption of protein arginine N-methyltransferase 2 regulates leptin signaling and produces leanness in vivo through loss of STAT3 methylation. Circ Res. 2010 Oct 15; 107(8):992-1001.
-
Nabel EG. On board with the Cures Acceleration Network. Sci Transl Med. 2010 May 19; 2(32):32ed2.
-
Akyürek LM, Boehm M, Olive M, Zhou AX, San H, Nabel EG. Deficiency of cyclin-dependent kinase inhibitors p21Cip1 and p27Kip1 accelerates atherogenesis in apolipoprotein E-deficient mice. Biochem Biophys Res Commun. 2010 May 28; 396(2):359-63.
-
Nabel E. Obama's research funding boost for medicine. Eur Heart J. 2009 Dec; 30(23):2821-3.
-
Nabel EG. Linking biomedical research to health care. J Clin Invest. 2009 Oct; 119(10):2858.
-
Guttmacher AE, Nabel EG, Collins FS. Why data-sharing policies matter. Proc Natl Acad Sci U S A. 2009 Oct 6; 106(40):16894.
-
Blaisdell CJ, Gail DB, Nabel EG. National Heart, Lung, and Blood Institute perspective: lung progenitor and stem cells--gaps in knowledge and future opportunities. Stem Cells. 2009 Sep; 27(9):2263-70.
-
Daar AS, Nabel EG, Pramming SK, Anderson W, Beaudet A, Liu D, Katoch VM, Borysiewicz LK, Glass RI, Bell J. The global alliance for chronic diseases. Science. 2009 Jun 26; 324(5935):1642.
-
Nabel EG, Stevens S, Smith R. Combating chronic disease in developing countries. Lancet. 2009 Jun 13; 373(9680):2004-6.
-
Nabel E. Changes in the research landscape require a new approach, while continuing to fund the highest scientific priorities. Jennifer Taylor talks with Dr Elizabeth Nabel, Director of the National Heart, Lung, and Blood Institute at the National Institutes of Health (NIH) National Library. Eur Heart J. 2009 Jun; 30(12):1423-5.
-
Cimato T, Beers J, Ding S, Ma M, McCoy JP, Boehm M, Nabel EG. Neuropilin-1 identifies endothelial precursors in human and murine embryonic stem cells before CD34 expression. Circulation. 2009 Apr 28; 119(16):2170-8.
-
Nabel EG. Notes from the Director, National Heart, Lung, and Blood Institute: transitions. Blood. 2009 Mar 26; 113(13):2875-7.
-
Nabel EG, Lauer MS. The cardiovascular programs of the National Heart, Lung, and Blood Institute: from vision to action to impact. J Am Coll Cardiol. 2009 Mar 24; 53(12):1082-3.
-
Nabel EG. National Heart, Lung, and Blood Institute: transitions. Circulation. 2009 Mar 17; 119(10):1453-5.
-
Lee TH, Hillis LD, Nabel EG. CABG vs. stenting--clinical implications of the SYNTAX trial. N Engl J Med. 2009 Feb 19; 360(8):e10.
-
Nabel EG. Notes from the NHLBI director: transitions. Am J Respir Crit Care Med. 2009 Feb 15; 179(4):263-4.
-
Langenickel TH, Olive M, Boehm M, San H, Crook MF, Nabel EG. KIS protects against adverse vascular remodeling by opposing stathmin-mediated VSMC migration in mice. J Clin Invest. 2008 Dec; 118(12):3848-59.
-
Capell BC, Olive M, Erdos MR, Cao K, Faddah DA, Tavarez UL, Conneely KN, Qu X, San H, Ganesh SK, Chen X, Avallone H, Kolodgie FD, Virmani R, Nabel EG, Collins FS. A farnesyltransferase inhibitor prevents both the onset and late progression of cardiovascular disease in a progeria mouse model. Proc Natl Acad Sci U S A. 2008 Oct 14; 105(41):15902-7.
-
O'Donnell CJ, Nabel EG. Cardiovascular genomics, personalized medicine, and the National Heart, Lung, and Blood Institute: part I: the beginning of an era. Circ Cardiovasc Genet. 2008 Oct; 1(1):51-7.
-
Zerhouni EA, Nabel EG. Protecting aggregate genomic data. Science. 2008 Oct 3; 322(5898):44.
-
Nabel EG, Shurin SB. A recommitment to sickle cell disease research. Blood. 2008 May 15; 111(10):4852-3.
-
Nabel EG. The physician-scientist: a value proposition. J Clin Invest. 2008 Apr; 118(4):1233-5.
-
Shurin SB, Nabel EG. Pharmacogenomics--ready for prime time? N Engl J Med. 2008 Mar 6; 358(10):1061-3.
-
Merideth MA, Gordon LB, Clauss S, Sachdev V, Smith AC, Perry MB, Brewer CC, Zalewski C, Kim HJ, Solomon B, Brooks BP, Gerber LH, Turner ML, Domingo DL, Hart TC, Graf J, Reynolds JC, Gropman A, Yanovski JA, Gerhard-Herman M, Collins FS, Nabel EG, Cannon RO, Gahl WA, Introne WJ. Phenotype and course of Hutchinson-Gilford progeria syndrome. N Engl J Med. 2008 Feb 7; 358(6):592-604.
-
Nabel EG. Notes from the NHLBI director: shaping the future of research--the NHLBI strategic plan. Am J Respir Crit Care Med. 2007 Dec 15; 176(12):1178.
-
Nabel EG. Shaping the future of research: the NHLBI strategic plan. Blood. 2007 Dec 15; 110(13):4143.
-
Daar AS, Singer PA, Persad DL, Pramming SK, Matthews DR, Beaglehole R, Bernstein A, Borysiewicz LK, Colagiuri S, Ganguly N, Glass RI, Finegood DT, Koplan J, Nabel EG, Sarna G, Sarrafzadegan N, Smith R, Yach D, Bell J. Grand challenges in chronic non-communicable diseases. Nature. 2007 Nov 22; 450(7169):494-6.
-
Nabel EG. Notes from the director of the National Heart, Lung, and Blood Institute: shaping the future of research: the NHLBI strategic plan. Circulation. 2007 Nov 20; 116(21):2479-80.
-
Nabel EG. Shaping the future of research: the NHLBI strategic plan. Circ Res. 2007 Oct 26; 101(9):849-50.
-
True AL, Olive M, Boehm M, San H, Westrick RJ, Raghavachari N, Xu X, Lynn EG, Sack MN, Munson PJ, Gladwin MT, Nabel EG. Heme oxygenase-1 deficiency accelerates formation of arterial thrombosis through oxidative damage to the endothelium, which is rescued by inhaled carbon monoxide. Circ Res. 2007 Oct 26; 101(9):893-901.
-
New models of collaboration in genome-wide association studies: the Genetic Association Information Network. Nat Genet. 2007 Sep; 39(9):1045-51.
-
Nabel EG, Shurin SB. Notes from the NHLBI Director: National Heart, Lung, and Blood Institute core values and shaping the 2007 budget. Am J Respir Crit Care Med. 2007 Sep 1; 176(5):430.
-
Crook MF, Olive M, Xue HH, Langenickel TH, Boehm M, Leonard WJ, Nabel EG. GA-binding protein regulates KIS gene expression, cell migration, and cell cycle progression. FASEB J. 2008 Jan; 22(1):225-35.
-
Nabel EG, Shurin SB. Notes from the Director, National Heart, Lung, and Blood Institute: NHLBI core values and shaping the 2007 budget. Blood. 2007 Aug 15; 110(4):1091.
-
Nabel EG, Shurin SB. Notes from the Director, National Heart, Lung, and Blood Institute: NHLBI core values and shaping the 2007 budget. Circulation. 2007 Aug 7; 116(6):683-4.
-
Capell BC, Collins FS, Nabel EG. Mechanisms of cardiovascular disease in accelerated aging syndromes. Circ Res. 2007 Jul 6; 101(1):13-26.
-
Nabel EG, Shurin SB, Simons-Morton DG, Gordon D. Data and safety monitoring of rosiglitazone trials. Lancet. 2007 Jun 23; 369(9579):2077.
-
Ganesh SK, Sharma Y, Dayhoff J, Fales HM, Van Eyk J, Kickler TS, Billings EM, Nabel EG. Detection of venous thromboembolism by proteomic serum biomarkers. PLoS One. 2007; 2(6):e544.
-
Kiley JP, Nabel EG. Treating COPD. N Engl J Med. 2007 Feb 22; 356(8):867.
-
Nabel EG. Conflict of interest--or conflict of priorities? N Engl J Med. 2006 Nov 30; 355(22):2365-7.
-
Nakahira K, Kim HP, Geng XH, Nakao A, Wang X, Murase N, Drain PF, Wang X, Sasidhar M, Nabel EG, Takahashi T, Lukacs NW, Ryter SW, Morita K, Choi AM. Carbon monoxide differentially inhibits TLR signaling pathways by regulating ROS-induced trafficking of TLRs to lipid rafts. J Exp Med. 2006 Oct 2; 203(10):2377-89.
-
Nabel EG. The Women's Health Initiative. Science. 2006 Sep 22; 313(5794):1703.
-
Alexander DF, Alving BM, Battey JF, Berg JM, Collins FS, Fauci AS, Gallin JI, Grady PA, Hodes RJ, Hrynkow SH, Insel TR, Jones JF, Katz SI, Landis SC, Li TK, Lindberg DA, Nabel EG, Niederhuber JE, Pettigrew RI, Rodgers GP, Ruffin J, Scarpa A, Schwartz DA, Sieving PA, Straus SE, Tabak LA, Volkow ND. Response to: "Rescuing the NIH before it is too late". J Clin Invest. 2006 Jun; 116(6):1462-3.
-
Ganesh L, Yoshimoto T, Moorthy NC, Akahata W, Boehm M, Nabel EG, Nabel GJ. Protein methyltransferase 2 inhibits NF-kappaB function and promotes apoptosis. Mol Cell Biol. 2006 May; 26(10):3864-74.
-
Yoshimoto T, Boehm M, Olive M, Crook MF, San H, Langenickel T, Nabel EG. The arginine methyltransferase PRMT2 binds RB and regulates E2F function. Exp Cell Res. 2006 Jul 1; 312(11):2040-53.
-
Varga R, Eriksson M, Erdos MR, Olive M, Harten I, Kolodgie F, Capell BC, Cheng J, Faddah D, Perkins S, Avallone H, San H, Qu X, Ganesh S, Gordon LB, Virmani R, Wight TN, Nabel EG, Collins FS. Progressive vascular smooth muscle cell defects in a mouse model of Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci U S A. 2006 Feb 28; 103(9):3250-5.
-
Spiegel AM, Nabel EG. NIH research on obesity and type 2 diabetes: providing the scientific evidence base for actions to improve health. Nat Med. 2006 Jan; 12(1):67-9.
-
Nallamshetty S, Crook M, Boehm M, Yoshimoto T, Olive M, Nabel EG. The cell cycle regulator p27Kip1 interacts with MCM7, a DNA replication licensing factor, to inhibit initiation of DNA replication. FEBS Lett. 2005 Dec 5; 579(29):6529-36.
-
Ganesh SK, Nabel EG. Genomics of in-stent restenosis: early insights into a complex disease. Circulation. 2005 Oct 18; 112(16):2378-9.
-
Nabel EG. Notes from the Director National Heart, Lung, and Blood Institute: fostering the independence of new investigators. Circulation. 2005 Oct 4; 112(14):2217-8.
-
Nabel EG. Notes from the NHLBI director: fostering the independence of new investigators. Am J Respir Crit Care Med. 2005 Oct 1; 172(7):797.
-
Nabel EG. Fostering the independence of new investigators. Sleep. 2005 Oct; 28(10):1221-2.
-
Nabel EG. Notes from the NHLBI Director: a vision for the future: opportunities and challenges. Am J Respir Crit Care Med. 2005 Aug 1; 172(3):266-7.
-
Nabel EG. A vision for the future: notes from the NHLBI director. Blood. 2005 Jul 15; 106(2):399-400.
-
Nabel EG. A vision for the future: opportunities and challenges: notes from the director of the National Heart, Lung, and Blood Institute. Circulation. 2005 Jul 5; 112(1):145-6.
-
Nabel EG. A vision for the future: opportunities and challenges. Sleep. 2005 Jul; 28(7):788-9.
-
Spiegel A, Nabel E, Volkow N, Landis S, Li TK. Obesity on the brain. Nat Neurosci. 2005 May; 8(5):552-3.
-
Nabel EG. Interview with Dr. Elizabeth G. Nabel, Director, National Heart, Lung, and Blood Institute. Interview by Stuart F. Quan. J Clin Sleep Med. 2005 Apr 15; 1(2):199-201.
-
Zheng G, Joo J, Ganesh SK, Nabel EG, Geller NL. On averaging power for genetic association and linkage studies. Hum Hered. 2005; 59(1):14-20.
-
Stanford SJ, Hislop AA, Oltmanns U, Nabel EG, Sang H, Haworth SG, Mitchell JA. Transition from placental to air breathing stimulates haem-oxygenase-1 expression without functional consequence for pulmonary vascular adaptation in pigs and mice. Br J Pharmacol. 2005 Feb; 144(4):467-76.
-
Sullivan NJ, Peterson M, Yang ZY, Kong WP, Duckers H, Nabel E, Nabel GJ. Ebola virus glycoprotein toxicity is mediated by a dynamin-dependent protein-trafficking pathway. J Virol. 2005 Jan; 79(1):547-53.
-
Ganesh SK, Skelding KA, Mehta L, O'Neill K, Joo J, Zheng G, Goldstein J, Simari R, Billings E, Geller NL, Holmes D, O'Neill WW, Nabel EG. Rationale and study design of the CardioGene Study: genomics of in-stent restenosis. Pharmacogenomics. 2004 Oct; 5(7):952-1004.
-
Boehm M, Olive M, True AL, Crook MF, San H, Qu X, Nabel EG. Bone marrow-derived immune cells regulate vascular disease through a p27(Kip1)-dependent mechanism. J Clin Invest. 2004 Aug; 114(3):419-26.
-
Li R, Faria TN, Boehm M, Nabel EG, Gudas LJ. Retinoic acid causes cell growth arrest and an increase in p27 in F9 wild type but not in F9 retinoic acid receptor beta2 knockout cells. Exp Cell Res. 2004 Mar 10; 294(1):290-300.
-
Bairey Merz N, Bonow RO, Sopko G, Balaban RS, Cannon RO, Gordon D, Hand MM, Hayes SN, Lewis JF, Long T, Manolio TA, Maseri A, Nabel EG, Desvigne Nickens P, Pepine CJ, Redberg RF, Rossouw JE, Selker HP, Shaw LJ, Waters DD. Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002: executive summary. Circulation. 2004 Feb 17; 109(6):805-7.
-
Nabel EG, Selker HP, Califf RM, Canto JG, Cao JJ, Desvigne-Nikkens P, Goldberg RJ, Finnegan JR, Vaccarino V, Virmani R. Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002: Section 3: diagnosis and treatment of acute cardiac ischemia: gender issues. Circulation. 2004 Feb 17; 109(6):e50-2.
-
Nabel EG. Cardiovascular disease. N Engl J Med. 2003 Jul 3; 349(1):60-72.
-
Lo C, Nabel E, Balaban R. Meeting report: NHLBI symposium on phenotyping: mouse cardiovascular function and development. Physiol Genomics. 2003 May 13; 13(3):185-6.
-
Boehm M, Nabel EG. The cell cycle and cardiovascular diseases. Prog Cell Cycle Res. 2003; 5:19-30.
-
Engel FB, Hauck L, Boehm M, Nabel EG, Dietz R, von Harsdorf R. p21(CIP1) Controls proliferating cell nuclear antigen level in adult cardiomyocytes. Mol Cell Biol. 2003 Jan; 23(2):555-65.
-
Kim TH, Skelding KA, Nabel EG, Simari RD. What can cardiovascular gene transfer learn from genomics: and vice versa? Physiol Genomics. 2002 Dec 3; 11(3):179-82.
-
Boehm M, Nabel EG. Angiotensin-converting enzyme 2--a new cardiac regulator. N Engl J Med. 2002 Nov 28; 347(22):1795-7.
-
Nabel EG. CDKs and CKIs: molecular targets for tissue remodelling. Nat Rev Drug Discov. 2002 Aug; 1(8):587-98.
-
Boehm M, Yoshimoto T, Crook MF, Nallamshetty S, True A, Nabel GJ, Nabel EG. A growth factor-dependent nuclear kinase phosphorylates p27(Kip1) and regulates cell cycle progression. EMBO J. 2002 Jul 1; 21(13):3390-401.
-
Vannan M, McCreery T, Li P, Han Z, Unger E, Kuersten B, Nabel E, Rajagopalan S. Ultrasound-mediated transfection of canine myocardium by intravenous administration of cationic microbubble-linked plasmid DNA. J Am Soc Echocardiogr. 2002 Mar; 15(3):214-8.
-
Nabel EG. Stem cells combined with gene transfer for therapeutic vasculogenesis: magic bullets? Circulation. 2002 Feb 12; 105(6):672-4.
-
Akyürek LM, San H, Nabel EG, Singh R, Simari RD. Gene transfer to arteries. Curr Protoc Hum Genet. 2002 Feb; Chapter 13:Unit13.1.
-
Nabel EG, Boehm M, Akyurek LM, Yoshimoto T, Crook MF, Olive M, San H, Qu X. Cell cycle signaling and cardiovascular disease. Cold Spring Harb Symp Quant Biol. 2002; 67:163-70.
-
Nabel EG. The golden egg--making good on discovery and translation. Trends Cardiovasc Med. 2002 Jan; 12(1):3-4.
-
Rajagopalan S, Shah M, Luciano A, Crystal R, Nabel EG. Adenovirus-mediated gene transfer of VEGF(121) improves lower-extremity endothelial function and flow reserve. Circulation. 2001 Aug 14; 104(7):753-5.
-
Lederman RJ, Raylman RR, Fisher SJ, Kison PV, San H, Nabel EG, Wahl RL. Detection of atherosclerosis using a novel positron-sensitive probe and 18-fluorodeoxyglucose (FDG). Nucl Med Commun. 2001 Jul; 22(7):747-53.
-
Boehm M, Nabel EG. Cell cycle and cell migration: new pieces to the puzzle. Circulation. 2001 Jun 19; 103(24):2879-81.
-
Duckers HJ, Boehm M, True AL, Yet SF, San H, Park JL, Clinton Webb R, Lee ME, Nabel GJ, Nabel EG. Heme oxygenase-1 protects against vascular constriction and proliferation. Nat Med. 2001 Jun; 7(6):693-8.
-
Akyürek LM, Nallamshetty S, Aoki K, San H, Yang ZY, Nabel GJ, Nabel EG. Coexpression of guanylate kinase with thymidine kinase enhances prodrug cell killing in vitro and suppresses vascular smooth muscle cell proliferation in vivo. Mol Ther. 2001 May; 3(5 Pt 1):779-86.
-
Aoki K, Kurooka M, Chen JJ, Petryniak J, Nabel EG, Nabel GJ. Extracellular matrix interacts with soluble CD95L: retention and enhancement of cytotoxicity. Nat Immunol. 2001 Apr; 2(4):333-7.
-
Akyürek LM, Yang ZY, Aoki K, San H, Nabel GJ, Parmacek MS, Nabel EG. SM22alpha promoter targets gene expression to vascular smooth muscle cells in vitro and in vivo. Mol Med. 2000 Nov; 6(11):983-91.
-
Nabel EG. Coronary heart disease in women--an ounce of prevention. N Engl J Med. 2000 Aug 24; 343(8):572-4.
-
Yang ZY, Duckers HJ, Sullivan NJ, Sanchez A, Nabel EG, Nabel GJ. Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury. Nat Med. 2000 Aug; 6(8):886-9.
-
Aoki K, Akyürek LM, San H, Leung K, Parmacek MS, Nabel EG, Nabel GJ. Restricted expression of an adenoviral vector encoding Fas ligand (CD95L) enhances safety for cancer gene therapy. Mol Ther. 2000 Jun; 1(6):555-65.
-
Tanner FC, Boehm M, Akyürek LM, San H, Yang ZY, Tashiro J, Nabel GJ, Nabel EG. Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation. Circulation. 2000 May 2; 101(17):2022-5.
-
Tanner FC, Meier P, Greutert H, Champion C, Nabel EG, Lüscher TF. Nitric oxide modulates expression of cell cycle regulatory proteins: a cytostatic strategy for inhibition of human vascular smooth muscle cell proliferation. Circulation. 2000 Apr 25; 101(16):1982-9.
-
Sjöland H, Eitzman DT, Gordon D, Westrick R, Nabel EG, Ginsburg D. Atherosclerosis progression in LDL receptor-deficient and apolipoprotein E-deficient mice is independent of genetic alterations in plasminogen activator inhibitor-1. Arterioscler Thromb Vasc Biol. 2000 Mar; 20(3):846-52.
-
Nabel EG. New approaches to pulmonary hypertension: will therapies in mice work in humans? Circulation. 2000 Feb 29; 101(8):839-40.
-
Eitzman DT, Westrick RJ, Nabel EG, Ginsburg D. Plasminogen activator inhibitor-1 and vitronectin promote vascular thrombosis in mice. Blood. 2000 Jan 15; 95(2):577-80.
-
Duckers HJ, Nabel EG. Prospects for genetic therapy of cardiovascular disease. Med Clin North Am. 2000 Jan; 84(1):199-213.
-
Nabel EG. Delivering genes to the heart--right where it counts! Nat Med. 1999 Feb; 5(2):141-2.
-
Nabel EG. Gene therapy for cardiovascular diseases. J Nucl Cardiol. 1999 Jan-Feb; 6(1 Pt 1):69-75.
-
Simari RD, Yang ZY, Ling X, Stephan D, Perkins ND, Nabel GJ, Nabel EG. Requirements for enhanced transgene expression by untranslated sequences from the human cytomegalovirus immediate-early gene. Mol Med. 1998 Nov; 4(11):700-6.
-
Danthinne X, Aoki K, Kurachi AL, Nabel GJ, Nabel EG. Combination gene delivery of the cell cycle inhibitor p27 with thymidine kinase enhances prodrug cytotoxicity. J Virol. 1998 Nov; 72(11):9201-7.
-
Rekhter MD, Shah N, Simari RD, Work C, Kim JS, Nabel GJ, Nabel EG, Gordon D. Graft permeabilization facilitates gene therapy of transplant arteriosclerosis in a rabbit model. Circulation. 1998 Sep 29; 98(13):1335-41.
-
Duckers HJ, Nabel EG. Gene therapy for coronary artery disease: The University of Michigan Program. Semin Interv Cardiol. 1998 Sep-Dec; 3(3-4):201-4.
-
Rekhter MD, Simari RD, Work CW, Nabel GJ, Nabel EG, Gordon D. Gene transfer into normal and atherosclerotic human blood vessels. Circ Res. 1998 Jun 29; 82(12):1243-52.
-
Tanner FC, Yang ZY, Duckers E, Gordon D, Nabel GJ, Nabel EG. Expression of cyclin-dependent kinase inhibitors in vascular disease. Circ Res. 1998 Feb 23; 82(3):396-403.
-
Yang Z, Delgado R, Xu L, Todd RF, Nabel EG, Sanchez A, Nabel GJ. Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins. Science. 1998 Feb 13; 279(5353):1034-7.
-
Xu L, Sanchez A, Yang Z, Zaki SR, Nabel EG, Nichol ST, Nabel GJ. Immunization for Ebola virus infection. Nat Med. 1998 Jan; 4(1):37-42.
-
Arai H, Gordon D, Nabel EG, Nabel GJ. Gene transfer of Fas ligand induces tumor regression in vivo. Proc Natl Acad Sci U S A. 1997 Dec 9; 94(25):13862-7.
-
Stephan D, San H, Yang ZY, Gordon D, Goelz S, Nabel GJ, Nabel EG. Inhibition of vascular smooth muscle cell proliferation and intimal hyperplasia by gene transfer of beta-interferon. Mol Med. 1997 Sep; 3(9):593-9.
-
Tanner FC, Carr DP, Nabel GJ, Nabel EG. Transfection of human endothelial cells. Cardiovasc Res. 1997 Sep; 35(3):522-8.
-
Stephan D, Gasser B, San H, Schubnel M, Nabel GJ, Nabel EG. [Direct gene transfer in the rat kidney in vivo]. Arch Mal Coeur Vaiss. 1997 Aug; 90(8):1127-30.
-
Stephan D, San H, Gordon D, Nabel GJ, Nabel EG. [Gene transfer of interferon beta inhibits vascular smooth muscle cell proliferation in vitro and in animal model of arterial injury]. Arch Mal Coeur Vaiss. 1997 Aug; 90(8):1121-5.
-
Rodman DM, San H, Simari R, Stephan D, Tanner F, Yang Z, Nabel GJ, Nabel EG. In vivo gene delivery to the pulmonary circulation in rats: transgene distribution and vascular inflammatory response. Am J Respir Cell Mol Biol. 1997 Jun; 16(6):640-9.
-
Schott E, Tostes RC, San H, Paul M, Webb RC, Nabel EG. Expression of a recombinant preproendothelin-1 gene in arteries stimulates vascular contractility. Am J Physiol. 1997 May; 272(5 Pt 2):H2385-93.
-
Nabel EG, Simari R, Yang Z, San H, Nabel GJ. In vivo gene transfer: a biological tool. Ann N Y Acad Sci. 1997 Apr 15; 811:289-92.
-
Ohno T, Yang Z, Ling X, Jaffe M, Nabel EG, Normolle D, Nabel GJ. Combination gene transfer to potentiate tumor regression. Gene Ther. 1997 Apr; 4(4):361-6.
-
Stephan D, Nabel EG. Gene and other biological therapies for vascular diseases. Fundam Clin Pharmacol. 1997; 11(2):97-110.
-
Nabel GJ, Gordon D, Bishop DK, Nickoloff BJ, Yang ZY, Aruga A, Cameron MJ, Nabel EG, Chang AE. Immune response in human melanoma after transfer of an allogeneic class I major histocompatibility complex gene with DNA-liposome complexes. Proc Natl Acad Sci U S A. 1996 Dec 24; 93(26):15388-93.
-
Stephan DJ, Yang ZY, San H, Simari RD, Wheeler CJ, Felgner PL, Gordon D, Nabel GJ, Nabel EG. A new cationic liposome DNA complex enhances the efficiency of arterial gene transfer in vivo. Hum Gene Ther. 1996 Oct 1; 7(15):1803-12.
-
Yang Z, Simari RD, Tanner F, Stephan D, Nabel GJ, Nabel EG. Gene transfer approaches to the regulation of vascular cell proliferation. Semin Interv Cardiol. 1996 Sep; 1(3):181-4.
-
DeBruyne LA, Chang AE, Cameron MJ, Yang Z, Gordon D, Nabel EG, Nabel GJ, Bishop DK. Direct transfer of a foreign MHC gene into human melanoma alters T cell receptor V beta usage by tumor-infiltrating lymphocytes. Cancer Immunol Immunother. 1996 Sep; 43(1):49-58.
-
Yang ZY, Simari RD, Perkins ND, San H, Gordon D, Nabel GJ, Nabel EG. Role of the p21 cyclin-dependent kinase inhibitor in limiting intimal cell proliferation in response to arterial injury. Proc Natl Acad Sci U S A. 1996 Jul 23; 93(15):7905-10.
-
Simari RD, San H, Rekhter M, Ohno T, Gordon D, Nabel GJ, Nabel EG. Regulation of cellular proliferation and intimal formation following balloon injury in atherosclerotic rabbit arteries. J Clin Invest. 1996 Jul 1; 98(1):225-35.
-
Simari RD, Nabel EG. Genetic therapy. Semin Interv Cardiol. 1996 Mar; 1(1):77-83.
-
Pompili VJ, Gordon D, San H, Yang Z, Muller DW, Nabel GJ, Nabel EG. Expression and function of a recombinant PDGF B gene in porcine arteries. Arterioscler Thromb Vasc Biol. 1995 Dec; 15(12):2254-64.
-
Nabel EG. Gene therapy for vascular diseases. Atherosclerosis. 1995 Dec; 118 Suppl:S51-6.
-
Nabel GJ, Yang ZY, Nabel EG, Bishop K, Marquet M, Felgner PL, Gordon D, Chang AE. Direct gene transfer for treatment of human cancer. Ann N Y Acad Sci. 1995 Nov 27; 772:227-31.
-
Yang ZY, Perkins ND, Ohno T, Nabel EG, Nabel GJ. The p21 cyclin-dependent kinase inhibitor suppresses tumorigenicity in vivo. Nat Med. 1995 Oct; 1(10):1052-6.
-
Chang MW, Barr E, Seltzer J, Jiang YQ, Nabel GJ, Nabel EG, Parmacek MS, Leiden JM. Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science. 1995 Jan 27; 267(5197):518-22.
-
Nabel EG. Gene therapy for cardiovascular disease. Circulation. 1995 Jan 15; 91(2):541-8.
-
Fishel RS, Thourani V, Eisenberg SJ, Shai SY, Corson MA, Nabel EG, Bernstein KE, Berk BC. Fibroblast growth factor stimulates angiotensin converting enzyme expression in vascular smooth muscle cells. Possible mediator of the response to vascular injury. J Clin Invest. 1995 Jan; 95(1):377-87.
-
Chang MW, Ohno T, Gordon D, Lu MM, Nabel GJ, Nabel EG, Leiden JM. Adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene inhibits vascular smooth muscle cell proliferation and neointima formation following balloon angioplasty of the rat carotid artery. Mol Med. 1995 Jan; 1(2):172-81.
-
Muller DW, Gordon D, San H, Yang Z, Pompili VJ, Nabel GJ, Nabel EG. Catheter-mediated pulmonary vascular gene transfer and expression. Circ Res. 1994 Dec; 75(6):1039-49.
-
Liptay S, Schmid RM, Nabel EG, Nabel GJ. Transcriptional regulation of NF-kappa B2: evidence for kappa B-mediated positive and negative autoregulation. Mol Cell Biol. 1994 Dec; 14(12):7695-703.
-
Nabel EG, Yang Z, Muller D, Chang AE, Gao X, Huang L, Cho KJ, Nabel GJ. Safety and toxicity of catheter gene delivery to the pulmonary vasculature in a patient with metastatic melanoma. Hum Gene Ther. 1994 Sep; 5(9):1089-94.
-
Ohno T, Gordon D, San H, Pompili VJ, Imperiale MJ, Nabel GJ, Nabel EG. Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science. 1994 Aug 5; 265(5173):781-4.
-
Plautz GE, Nabel EG, Fox B, Yang ZY, Jaffe M, Gordon D, Chang A, Nabel GJ. Direct gene transfer for the understanding and treatment of human disease. Ann N Y Acad Sci. 1994 May 31; 716:144-53.
-
Nabel EG, Plautz GE, Nabel GJ. Recombinant growth factor gene expression in vascular cells in vivo. Ann N Y Acad Sci. 1994 Apr 18; 714:247-52.
-
Nabel EG, Pompili VJ, Plautz GE, Nabel GJ. Gene transfer and vascular disease. Cardiovasc Res. 1994 Apr; 28(4):445-55.
-
Nabel GJ, Nabel EG, Yang Z, Fox BA, Plautz GE, Gao X, Huang L, Shu S, Gordon D, Chang AE. Molecular genetic interventions for cancer. Cold Spring Harb Symp Quant Biol. 1994; 59:699-707.
-
Nabel GJ, Chang AE, Nabel EG, Plautz GE, Ensminger W, Fox BA, Felgner P, Shu S, Cho K. Immunotherapy for cancer by direct gene transfer into tumors. Hum Gene Ther. 1994 Jan; 5(1):57-77.
-
Nabel EG, Nabel GJ. Complex models for the study of gene function in cardiovascular biology. Annu Rev Physiol. 1994; 56:741-61.
-
Nabel GJ, Nabel EG, Yang ZY, Fox BA, Plautz GE, Gao X, Huang L, Shu S, Gordon D, Chang AE. Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. Proc Natl Acad Sci U S A. 1993 Dec 1; 90(23):11307-11.
-
Nabel EG, Shum L, Pompili VJ, Yang ZY, San H, Shu HB, Liptay S, Gold L, Gordon D, Derynck R, et al. Direct transfer of transforming growth factor beta 1 gene into arteries stimulates fibrocellular hyperplasia. Proc Natl Acad Sci U S A. 1993 Nov 15; 90(22):10759-63.
-
Shu HB, Agranoff AB, Nabel EG, Leung K, Duckett CS, Neish AS, Collins T, Nabel GJ. Differential regulation of vascular cell adhesion molecule 1 gene expression by specific NF-kappa B subunits in endothelial and epithelial cells. Mol Cell Biol. 1993 Oct; 13(10):6283-9.
-
Nabel EG, Nabel GJ. Direct gene transfer: basic studies and human therapies. Thromb Haemost. 1993 Jul 1; 70(1):202-3.
-
Nabel EG, Yang ZY, Plautz G, Forough R, Zhan X, Haudenschild CC, Maciag T, Nabel GJ. Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo. Nature. 1993 Apr 29; 362(6423):844-6.
-
Nabel EG, Yang Z, Liptay S, San H, Gordon D, Haudenschild CC, Nabel GJ. Recombinant platelet-derived growth factor B gene expression in porcine arteries induce intimal hyperplasia in vivo. J Clin Invest. 1993 Apr; 91(4):1822-9.
-
Nabel EG, Gordon D, Yang ZY, Xu L, San H, Plautz GE, Wu BY, Gao X, Huang L, Nabel GJ. Gene transfer in vivo with DNA-liposome complexes: lack of autoimmunity and gonadal localization. Hum Gene Ther. 1992 Dec; 3(6):649-56.
-
Treasure CB, Manoukian SV, Klein JL, Vita JA, Nabel EG, Renwick GH, Selwyn AP, Alexander RW, Ganz P. Epicardial coronary artery responses to acetylcholine are impaired in hypertensive patients. Circ Res. 1992 Oct; 71(4):776-81.
-
Stewart MJ, Plautz GE, Del Buono L, Yang ZY, Xu L, Gao X, Huang L, Nabel EG, Nabel GJ. Gene transfer in vivo with DNA-liposome complexes: safety and acute toxicity in mice. Hum Gene Ther. 1992 Jun; 3(3):267-75.
-
Nabel EG, Plautz G, Nabel GJ. Transduction of a foreign histocompatibility gene into the arterial wall induces vasculitis. Proc Natl Acad Sci U S A. 1992 Jun 1; 89(11):5157-61.
-
Nabel EG. Direct gene transfer into the arterial wall. J Vasc Surg. 1992 May; 15(5):931-2.
-
Nabel EG. Biology of the impaired endothelium. Am J Cardiol. 1991 Nov 4; 68(12):6C-8C.
-
Yao SN, Wilson JM, Nabel EG, Kurachi S, Hachiya HL, Kurachi K. Expression of human factor IX in rat capillary endothelial cells: toward somatic gene therapy for hemophilia B. Proc Natl Acad Sci U S A. 1991 Sep 15; 88(18):8101-5.
-
Plautz G, Nabel EG, Nabel GJ. Selective elimination of recombinant genes in vivo with a suicide retroviral vector. New Biol. 1991 Jul; 3(7):709-15.
-
Nabel EG, Plautz G, Nabel GJ. Gene transfer into vascular cells. J Am Coll Cardiol. 1991 May; 17(6 Suppl B):189B-194B.
-
McLenachan JM, Weidinger FF, Barry J, Yeung A, Nabel EG, Rocco MB, Selwyn AP. Relations between heart rate, ischemia, and drug therapy during daily life in patients with coronary artery disease. Circulation. 1991 Apr; 83(4):1263-70.
-
Nabel EG, Topol EJ, Galeana A, Ellis SG, Bates ER, Werns SW, Walton JA, Muller DW, Schwaiger M, Pitt B. A randomized placebo-controlled trial of combined early intravenous captopril and recombinant tissue-type plasminogen activator therapy in acute myocardial infarction. J Am Coll Cardiol. 1991 Feb; 17(2):467-73.
-
Plautz G, Nabel EG, Nabel GJ. Introduction of vascular smooth muscle cells expressing recombinant genes in vivo. Circulation. 1991 Feb; 83(2):578-83.
-
Nabel EG, Nabel GJ. Gene transfer and cardiovascular disease. Trends Cardiovasc Med. 1991 Jan-Feb; 1(1):12-7.
-
Nabel EG, Plautz G, Nabel GJ. Site-specific gene expression in vivo by direct gene transfer into the arterial wall. Science. 1990 Sep 14; 249(4974):1285-8.
-
Nabel EG, Selwyn AP, Ganz P. Large coronary arteries in humans are responsive to changing blood flow: an endothelium-dependent mechanism that fails in patients with atherosclerosis. J Am Coll Cardiol. 1990 Aug; 16(2):349-56.
-
Creager MA, Hirsch AT, Dzau VJ, Nabel EG, Cutler SS, Colucci WS. Baroreflex regulation of regional blood flow in congestive heart failure. Am J Physiol. 1990 May; 258(5 Pt 2):H1409-14.
-
Nabel EG, Selwyn AP, Ganz P. Paradoxical narrowing of atherosclerotic coronary arteries induced by increases in heart rate. Circulation. 1990 Mar; 81(3):850-9.
-
Vita JA, Treasure CB, Nabel EG, McLenachan JM, Fish RD, Yeung AC, Vekshtein VI, Selwyn AP, Ganz P. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation. 1990 Feb; 81(2):491-7.
-
Topol EJ, Ellis SG, Califf RM, George BS, Stump DC, Bates ER, Nabel EG, Walton JA, Candela RJ, Lee KL, et al. Combined tissue-type plasminogen activator and prostacyclin therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 4 Study Group. J Am Coll Cardiol. 1989 Oct; 14(4):877-84.
-
Nabel EG, Plautz G, Boyce FM, Stanley JC, Nabel GJ. Recombinant gene expression in vivo within endothelial cells of the arterial wall. Science. 1989 Jun 16; 244(4910):1342-4.
-
Gordon JB, Ganz P, Nabel EG, Fish RD, Zebede J, Mudge GH, Alexander RW, Selwyn AP. Atherosclerosis influences the vasomotor response of epicardial coronary arteries to exercise. J Clin Invest. 1989 Jun; 83(6):1946-52.
-
Ellis SG, O'Neill WW, Bates ER, Walton JA, Nabel EG, Werns SW, Topol EJ. Implications for patient triage from survival and left ventricular functional recovery analyses in 500 patients treated with coronary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 1989 May; 13(6):1251-9.
-
Ellis SG, O'Neill WW, Bates ER, Walton JA, Nabel EG, Topol EJ. Coronary angioplasty as primary therapy for acute myocardial infarction 6 to 48 hours after symptom onset: report of an initial experience. J Am Coll Cardiol. 1989 Apr; 13(5):1122-6.
-
Nabel EG, Barry J, Rocco MB, Mead K, Selwyn AP. Effects of dosing intervals on the development of tolerance to high dose transdermal nitroglycerin. Am J Cardiol. 1989 Mar 15; 63(11):663-9.
-
Werns SW, Walton JA, Hsia HH, Nabel EG, Sanz ML, Pitt B. Evidence of endothelial dysfunction in angiographically normal coronary arteries of patients with coronary artery disease. Circulation. 1989 Feb; 79(2):287-91.
-
Barry J, Mead K, Nabel EG, Rocco MB, Campbell S, Fenton T, Mudge GH, Selwyn AP. Effect of smoking on the activity of ischemic heart disease. JAMA. 1989 Jan 20; 261(3):398-402.
-
Rocco MB, Nabel EG, Campbell S, Goldman L, Barry J, Mead K, Selwyn AP. Prognostic importance of myocardial ischemia detected by ambulatory monitoring in patients with stable coronary artery disease. Circulation. 1988 Oct; 78(4):877-84.
-
Nabel EG, Barry J, Rocco MB, Campbell S, Mead K, Fenton T, Orav EJ, Selwyn AP. Variability of transient myocardial ischemia in ambulatory patients with coronary artery disease. Circulation. 1988 Jul; 78(1):60-7.
-
Creager MA, Hirsch AT, Nabel EG, Cutler SS, Colucci WS, Dzau VJ. Responsiveness of atrial natriuretic factor to reduction in right atrial pressure in patients with chronic congestive heart failure. J Am Coll Cardiol. 1988 Jun; 11(6):1191-8.
-
Barry J, Selwyn AP, Nabel EG, Rocco MB, Mead K, Campbell S, Rebecca G. Frequency of ST-segment depression produced by mental stress in stable angina pectoris from coronary artery disease. Am J Cardiol. 1988 May 1; 61(13):989-93.
-
Nabel EG, Shook TL, Meyerovitz M, Ganz P, Selwyn AP, Friedman PL. Detection of pacing-induced myocardial ischemia by endocardial electrograms recorded during cardiac catheterization. J Am Coll Cardiol. 1988 May; 11(5):983-92.
-
Nabel EG, Berk BC, Brock TA, Smith TW. Na+-Ca2+ exchange in cultured vascular smooth muscle cells. Circ Res. 1988 Mar; 62(3):486-93.
-
Nabel EG, Ganz P, Gordon JB, Alexander RW, Selwyn AP. Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test. Circulation. 1988 Jan; 77(1):43-52.
-
Fish RD, Nabel EG, Selwyn AP, Ludmer PL, Mudge GH, Kirshenbaum JM, Schoen FJ, Alexander RW, Ganz P. Responses of coronary arteries of cardiac transplant patients to acetylcholine. J Clin Invest. 1988 Jan; 81(1):21-31.
-
Barry J, Campbell S, Nabel EG, Mead K, Selwyn AP. Ambulatory monitoring of the digitized electrocardiogram for detection and early warning of transient myocardial ischemia in angina pectoris. Am J Cardiol. 1987 Sep 1; 60(7):483-8.
-
Nabel EG, Colucci WS, Lilly LS, Cutler SS, Majzoub JA, St John Sutton MG, Dzau VJ, Creager MA. Relationship of cardiac chamber volume to baroreflex activity in normal humans. J Clin Endocrinol Metab. 1987 Sep; 65(3):475-81.
-
Nabel EG, Rocco MB, Selwyn AB. Characteristics and significance of ischemia detected by ambulatory electrocardiographic monitoring. Circulation. 1987 Jun; 75(6 Pt 2):V74-83.
-
Nabel EG, Rocco MB, Barry J, Campbell S, Selwyn AP. Asymptomatic ischemia in patients with coronary artery disease. JAMA. 1987 Apr 10; 257(14):1923-8.
-
Rocco MB, Nabel EG, Selwyn AP. Circadian rhythms and coronary artery disease. Am J Cardiol. 1987 Mar 9; 59(7):13C-17C.
-
Rocco MB, Barry J, Campbell S, Nabel E, Cook EF, Goldman L, Selwyn AP. Circadian variation of transient myocardial ischemia in patients with coronary artery disease. Circulation. 1987 Feb; 75(2):395-400.
-
Rocco MB, Nabel E, Selwyn AP. Development and validation of ambulatory monitoring to characterize ischemic heart disease out of hospital. Cardiol Clin. 1986 Nov; 4(4):659-68.
-
Campbell S, Barry J, Rocco MB, Nabel EG, Mead-Walters K, Rebecca GS, Selwyn AP. Features of the exercise test that reflect the activity of ischemic heart disease out of hospital. Circulation. 1986 Jul; 74(1):72-80.
-
Campbell S, Barry J, Rebecca GS, Rocco MB, Nabel EG, Wayne RR, Selwyn AP. Active transient myocardial ischemia during daily life in asymptomatic patients with positive exercise tests and coronary artery disease. Am J Cardiol. 1986 May 1; 57(13):1010-6.
-
Campbell S, Rocco MB, Nabel EG, Barry J, Rebecca GS, Deanfield JE, Selwyn AP. Factors determining the activity of ischemic heart disease. Am J Med. 1986 Apr 30; 80(4C):9-17.
-
Rocco MB, Campbell S, Barry J, Rebecca G, Nabel E, Deanfield J, Selwyn AP. Activity of transient myocardial ischemia out of hospital in coronary artery disease and implications for management. Am J Cardiol. 1985 Dec 27; 56(17):19I-22I.
-
Nabel EG, Gibbons GH, Dzau VJ. Pathophysiology of experimental renovascular hypertension. Am J Kidney Dis. 1985 Apr; 5(4):A111-9.
This graph shows the total number of publications by year.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
|
Nabel's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|